Skip to main content

Table 2 Incidence of CVD and death (percentage of participants) according to baseline diabetes and CVD status

From: Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes

 

New T2D, no CVD

(n = 933)

New T2D, CVD

(n = 98)

P-value

Known T2D, no CVD

(n = 1138)

Known T2D, CVD

(n = 180)

P-value

New CVD events (%)

44 (4.7%)

25 (25.5%)

< 0.001

66 (5.8%)

60 (33.3%)

< 0.001

Death (%)

47 (5.0%)

16 (16.3%)

< 0.001

47 (4.1%)

27 (15.0%)

< 0.001

CVD or death (%)

88 (9.4%)

38 (38.8%)

< 0.001

110 (9.7%)

77 (42.8%)

< 0.001

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us